| IQVIA HLDGS DL-,01 |
| USA |
| Gesundheit |
| US46266C1053 / A2JSPM |
| QTS (Frankfurt) / IQV (NYSE) |
| FRA:QTS, ETR:QTS, QTS:GR, NYSE:IQV |
| S&P500 |
| https://www.iqvia.com/ |
|
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in de..
>Volltext.. |
| 34502.75 Mio. EUR |
| 47006.56 Mio. EUR |
| 14731.47 Mio. EUR |
| 3074.29 Mio. EUR |
| 1192.43 Mio. EUR |
| 7.06 EUR |
| 14084.52 Mio. EUR |
| 1655.52 Mio. EUR |
| 2444.69 Mio. EUR |
| 0.24 |
| 11.62% |
| 14.65% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 25.305.574 Euro. |
| IQVIA |
| 14.08.26 |